SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-014650
Filing Date
2024-04-15
Accepted
2024-04-15 17:02:59
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1695432
2 ex31-1.htm EX-31.1 16573
3 ex31-2.htm EX-31.2 16761
4 ex32-1.htm EX-32.1 7573
5 ex32-2.htm EX-32.2 7713
  Complete submission text file 0001493152-24-014650.txt   7448043

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20230630.xsd EX-101.SCH 47605
7 XBRL CALCULATION FILE orgs-20230630_cal.xml EX-101.CAL 71229
8 XBRL DEFINITION FILE orgs-20230630_def.xml EX-101.DEF 201592
9 XBRL LABEL FILE orgs-20230630_lab.xml EX-101.LAB 368721
10 XBRL PRESENTATION FILE orgs-20230630_pre.xml EX-101.PRE 282408
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 1422674
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38416 | Film No.: 24845348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)